BIOMAT Database Logo BIOMAT Database Logo

Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy. 2017

Ivan Gentile, and Antonio Riccardo Buonomo, and Alberto Enrico Maraolo, and Riccardo Scotto, and Federico De Zottis, and Gianfranco Di Renzo, and Guglielmo Borgia
Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples 'Federico II', Naples, Italy.

UI MeSH Term Description Entries
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010019 Osteomyelitis INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA. Osteomyelitides
D010397 Penicillanic Acid A building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed) Acid, Penicillanic
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078142 Tazobactam A penicillanic acid and sulfone derivative and potent BETA-LACTAMASE inhibitor that enhances the activity of other anti-bacterial agents against beta-lactamase producing bacteria. Tazobactam Sodium,YTR 830,YTR 830H,YTR-830,YTR830

Related Publications

Ivan Gentile, and Antonio Riccardo Buonomo, and Alberto Enrico Maraolo, and Riccardo Scotto, and Federico De Zottis, and Gianfranco Di Renzo, and Guglielmo Borgia
Successful treatment of three severe MDR or XDR Pseudomonas aeruginosa infections with ceftolozane/tazobactam.
November 2017, Future microbiology,
Ivan Gentile, and Antonio Riccardo Buonomo, and Alberto Enrico Maraolo, and Riccardo Scotto, and Federico De Zottis, and Gianfranco Di Renzo, and Guglielmo Borgia
Ceftolozane/tazobactam for the treatment of XDR Pseudomonas aeruginosa infections.
August 2018, Infection,
Ivan Gentile, and Antonio Riccardo Buonomo, and Alberto Enrico Maraolo, and Riccardo Scotto, and Federico De Zottis, and Gianfranco Di Renzo, and Guglielmo Borgia
Successful treatment of multidrug-resistant Pseudomonas aeruginosa pubic symphysis osteomyelitis with ceftolozane/tazobactam.
March 2017, BMJ case reports,
Ivan Gentile, and Antonio Riccardo Buonomo, and Alberto Enrico Maraolo, and Riccardo Scotto, and Federico De Zottis, and Gianfranco Di Renzo, and Guglielmo Borgia
Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam.
February 2017, Infection,
Ivan Gentile, and Antonio Riccardo Buonomo, and Alberto Enrico Maraolo, and Riccardo Scotto, and Federico De Zottis, and Gianfranco Di Renzo, and Guglielmo Borgia
Successful treatment of osteomyelitis caused by Pseudomonas aeruginosa.
November 1970, Journal of clinical pathology,
Ivan Gentile, and Antonio Riccardo Buonomo, and Alberto Enrico Maraolo, and Riccardo Scotto, and Federico De Zottis, and Gianfranco Di Renzo, and Guglielmo Borgia
Successful ceftolozane-tazobactam rescue therapy in a child with endocarditis caused by multidrug-resistant Pseudomonas aeruginosa.
August 2019, Journal of paediatrics and child health,
Ivan Gentile, and Antonio Riccardo Buonomo, and Alberto Enrico Maraolo, and Riccardo Scotto, and Federico De Zottis, and Gianfranco Di Renzo, and Guglielmo Borgia
Use of Ceftolozane-Tazobactam in Patient with Severe Medium Chronic Purulent Otitis by XDR Pseudomonas aeruginosa.
January 2019, Case reports in infectious diseases,
Ivan Gentile, and Antonio Riccardo Buonomo, and Alberto Enrico Maraolo, and Riccardo Scotto, and Federico De Zottis, and Gianfranco Di Renzo, and Guglielmo Borgia
Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane/tazobactam.
April 2017, The Journal of antimicrobial chemotherapy,
Ivan Gentile, and Antonio Riccardo Buonomo, and Alberto Enrico Maraolo, and Riccardo Scotto, and Federico De Zottis, and Gianfranco Di Renzo, and Guglielmo Borgia
Ceftolozane-tazobactam and Fosfomycin for rescue treatment of otogenous meningitis caused by XDR Pseudomonas aeruginosa: Case report and review of the literature.
January 2018, IDCases,
Ivan Gentile, and Antonio Riccardo Buonomo, and Alberto Enrico Maraolo, and Riccardo Scotto, and Federico De Zottis, and Gianfranco Di Renzo, and Guglielmo Borgia
Successful treatment of Pseudomonas aeruginosa osteomyelitis with antibiotic monotherapy of limited duration.
September 2017, The Journal of infection,
Copied contents to your clipboard!